Breast Cancer

, Volume 24, Issue 2, pp 180–190

DuCLOX-2/5 inhibition: a promising target for cancer chemoprevention

  • Swetlana Gautam
  • Subhadeep Roy
  • Mohd Nazam Ansari
  • Abdulaziz S. Saeedan
  • Shubhini A. Saraf
  • Gaurav Kaithwas
Review Article

DOI: 10.1007/s12282-016-0723-2

Cite this article as:
Gautam, S., Roy, S., Ansari, M.N. et al. Breast Cancer (2017) 24: 180. doi:10.1007/s12282-016-0723-2

Abstract

Cancer is a leading cause of death and major health concern worldwide. The animal and human studies support the presumption that inflammation directs the cancer initiation and progression. Cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) are the key players in the inflammatory cascade contributing towards the angiogenesis, tumor cell invasiveness, and disruption in the pathways of cellular proliferation/apoptosis. Contemporary studies have particularized a promising role of COX-2 and 5-LOX inhibitors in cancer chemoprevention. The present review is a pursuit to define implications of dual COX-2 and 5-LOX (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention.

Keywords

Angiogenesis Apoptosis Cyclooxygenase Lipoxygenase NSAIDs Proliferation 

Abbreviations

ATP

Adenosine triphosphate

AA

Arachidonic acid

Bcl-2

B cell chronic lymphocytic leukaemia-2

COX

Cyclooxygenase

ERK

Extracellular signal regulated kinase

GDP

Guanosine diphosphate

GTP

Guanosine triphosphate

HETE

Hydroeicosa-tetraenoic acid

HPETE

Hydroperoxyeicosa-tetraenoic acid

LXs

Lipoxins

LOX

Lipoxygenase

LTs

Leukotrienes

MAPK

Mitogen activated protein kinase

NSAIDs

Non-steroidal anti-inflammatory drugs

NF-Kb

Nuclear factor-kappa B

PPAR

Peroxisome proliferator activated receptor

PI3K/AKT

Phosphoinositide-3 kinase/AKT

PLA2

Phospholipase A2

PIP2

Phosphatidylinositol 4, 5-bisphosphate

PIP3

Phosphatidylinositol-3,4,5-triphosphate

PUFA

Polyunsaturated fatty acids

PKC

Protein kinase C

PGI2

Prostacyclin

PGs

Prostaglandins

RTKs

Receptor tyrosine kinase

RXR

Retinoid X receptor

TXs

Thromboxane

VEGF

Vascular endothelial growth factor

5-HETE

5-Hydroxytetraenoic acid

FLAP

5-LOX activating protein

Copyright information

© The Japanese Breast Cancer Society 2016

Authors and Affiliations

  • Swetlana Gautam
    • 1
  • Subhadeep Roy
    • 1
  • Mohd Nazam Ansari
    • 2
  • Abdulaziz S. Saeedan
    • 2
  • Shubhini A. Saraf
    • 1
  • Gaurav Kaithwas
    • 1
  1. 1.Department of Pharmaceutical Sciences, School of Biosciences and BiotechnologyBabasaheb Bhimrao Ambedkar University (A Central University)LucknowIndia
  2. 2.Department of Pharmacology, College of PharmacyPrince Sattam Bin Abdulaziz UniversityAl-KharjKingdom of Saudi Arabia